买专利_怎样_标准知识产权

2021-03-23 采集侠 网络整理
浏览

买专利_怎样_标准知识产权

Federal Trade Commission Suffers Another Setback in Its Campaign to End Pharmaceutical Reverse-Settlement Agreements Publications AntitrustAidan SynnottWilliam B. Michael Share this See Also AntitrustAidan SynnottWilliam B. Michael Share this June 27, 2012 Litigation partner Aidan Synnott and associate William Michael authored an article in Competition Policy International about developments in the Federal Trade Commission's campaign to end "reverse settlement" payments among manufacturers of branded and generic pharmaceuticals. In particular, the article, titled "Federal Trade Commission Suffers Another Setback in Its Campaign to End Pharmaceutical Reverse-Settlement Agreements," discusses Federal Trade Commission v. Watson Pharmaceuticals, in which the Eleventh Circuit Court of Appeals affirmed the dismissal of a complaint alleging that a reverse settlement payment, made by the holder of a pharmaceutical patent to two generic drug manufacturers, violated the antitrust laws. The decision renders reverse settlements "immune from antitrust attack" in the Eleventh Circuit in most circumstances, and further diminishes the FTC's chances of persuading other courts to adopt its policy position. »  Read the article

,商标侵权判决书,商标怎样注册,版权登记官费,知识产权服务平台,房屋抵押公证